Phenotype-first screening for the identification of novel drug targets

Drug Discovery Today

Volumn 10, Issue 4, 2005, Pages 275-282

  Austen, Matthias ^a   Dohrmann, Cord ^a  

^a DeveloGen AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; ETHYLNITROSOUREA;

CAENORHABDITIS ELEGANS; DROSOPHILA; DRUG SELECTIVITY; DRUG TARGETING; EMBRYONIC STEM CELL; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENETIC LINKAGE; GENETIC SCREENING; GENOMICS; HUMAN; MAMMAL CELL; MOLECULAR GENETICS; MUTAGENESIS; NONHUMAN; PHENOTYPE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSPOSON; ZEBRA FISH;

ANIMALS; DRUG DESIGN; GENE EXPRESSION PROFILING; GENOME; GENOMICS; HUMANS; MODELS, ANIMAL; MUTATION; PHENOTYPE;

EID: 13644256840     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(05)03368-4     Document Type: Review

References (70)

1. Balling R. ENU mutagenesis: analyzing gene function in mice. Annu. Rev. Genomics Hum. Genet. 2:2001;463-492
2. Skarnes W.C., et al. A public gene trap resource for mouse functional genomics. Nat. Genet. 36:2004;543-544
3. Horie K., et al. Characterization of Sleeping Beauty transposition and its application to genetic screening in mice. Mol. Cell. Biol. 23:2003;9189-9207
4. Russell W.L., et al. Specific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse. Proc. Natl. Acad. Sci. U. S. A. 76:1979;5818-5819
5. Justice M.J., et al. Mouse ENU mutagenesis. Hum. Mol. Genet. 8:1999;1955-1963
6. Vanhaesebroeck B., et al. Gene targeting: attention to detail. Cell. 118:2004;274-276
7. Patrucco E, et al. P13Kγ modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects. Cell. 118:2004;375-387
8. Thornton C.E., et al. Large numbers of mice established by in vitro fertilization with cryopreserved spermatozoa: implications and applications for genetic resource banks, mutagenesis screens, and mouse backcrosses. Mamm. Genome. 10:1999;987-992
9. Nolan P.M., et al. A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nat. Genet. 25:2000;440-443
10. Munroe R.J., et al. Mouse mutants from chemically mutagenized embryonic stem cells. Nat. Genet. 24:2000;318-321
11. Hrabe de Angelis M.H., et al. Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat. Genet. 25:2000;444-447
12. Carpinelli M.R., et al. Suppressor screen in Mpl-/- mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling. Proc. Natl. Acad. Sci. U. S. A. 101:2004;6553-6558
13. Streisinger G., et al. Production of clones of homozygous diploid zebra fish (Brachydanio rerio). Nature. 291:1981;293-296
14. Patton E.E., Zon L.I. The art and design of genetic screens: zebrafish. Nat. Rev. Genet. 2:2001;956-966
15. Driever W., et al. A genetic screen for mutations affecting embryogenesis in zebrafish. Development. 123:1996;37-46
16. Haffter P., et al. The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development. 123:1996;1-36
17. Nasevicius A., Ekker S.C. Effective targeted gene 'knockdown' in zebrafish. Nat. Genet. 26:2000;216-220
18. Wienholds E., et al. Efficient target-selected mutagenesis in zebrafish. Genome Res. 13:2003;2700-2707
19. Udvadia A.J., Linney E. Windows into development: historic, current, and future perspectives on transgenic zebrafish. Dev. Biol. 256:2003;1-17
20. Stainier D.Y., et al. Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. Development. 123:1996;285-292
21. Chen J.N., et al. Mutations affecting the cardiovascular system and other internal organs in zebrafish. Development. 123:1996;293-302
22. Habeck H., et al. Analysis of a zebrafish VEGF receptor mutant reveals specific disruption of angiogenesis. Curr. Biol. 12:2002;1405-1412
23. Childs S., et al. Zebrafish dracula encodes ferrochelatase and its mutation provides a model for erythropoietic protoporphyria. Curr. Biol. 10:2000;1001-1004
24. Lawson N.D., Weinstein B.M. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev. Biol. 248:2002;307-318
25. Farber S.A., et al. Genetic analysis of digestive physiology using fluorescent phospholipid reporters. Science. 292:2001;1385-1388
26. North T.E., Zon L.I. Modeling human hematopoietic and cardiovascular diseases in zebrafish. Dev. Dyn. 228:2003;568-583
27. Jagadeeswaran P., et al. Haemostatic screening and identification of zebrafish mutants with coagulation pathway defects: an approach to identifying novel haemostatic genes in man. Br. J. Haematol. 110:2000;946-956
28. Amatruda J.F., et al. Zebrafish as a cancer model system. Cancer Cell. 1:2002;229-231
29. Amsterdam A., et al. Identification of 315 genes essential for early zebrafish development. Proc. Natl. Acad. Sci. U. S. A. 101:2004;12792-12797
30. Kawakami K., et al. A transposon-mediated gene trap approach identifies developmentally regulated genes in zebrafish. Dev. Cell. 7:2004;133-144
31. Kornberg T.B., Krasnow M.A. The Drosophila genome sequence: implications for biology and medicine. Science. 287:2000;2218-2220
32. Rubin G.M., et al. Comparative genomics of the eukaryotes. Science. 287:2000;2204-2215
33. Kazemi-Esfarjani P., Benzer S. Genetic suppression of polyglutamine toxicity in Drosophila. Science. 287:2000;1837-1840
34. 2 deprivation in Drosophila melanogaster. J. Clin. Invest. 107:2001;685-693
35. Pagliarini R., Xu T. A genetic screen in Drosophila for metastatic behaviour. Science. 302:2003;1227-1231
36. Potter C.J, et al. Drosophila in cancer research. An expanding role. Trends Genet. 16:2000;33-39
37. Dohrmann C.E. Target discovery in metabolic disease. Drug Discov. Today. 9:2004;785-794
38. Wolf F.W., Heberlein U. Invertebrate models of drug abuse. J. Neurobiol. 54:2003;161-178
39. Tracey W.D. Jr, et al. painless, a Drosophila gene essential for nociception. Cell. 113:2003;261-273
40. Rubin G.M., Lewis E.B. A brief history of Drosophila's contributions to genome research. Science. 287:2000;2216-2218
41. St Johnston D. The art and design of genetic screens: Drosophila melanogaster. Nat. Rev. Genet. 3:2002;176-188
42. Adams M.D., et al. The genome sequence of Drosophila melanogaster. Science. 287:2000;2185-2195
43. Dohrmann C.E. Target discovery in metabolic disease. Drug Discov. Today. 9:2004;785-794
44. Hader T., et al. Control of triglyceride storage by a WD40/TPR-domain protein. EMBO Rep. 4:2003;511-516
45. Frei C., Edgar B.A. Drosophila cyclin D/Cdk4 requires Hif-1 prolyl hydroxylase to drive cell growth. Dev. Cell. 6:2004;241-251
46. Brenner S. The genetics of Caenorhabditis elegans. Genetics. 77:1974;71-94
47. Jorgensen E.M., Mango S.E. The art and design of genetic screens: Caenorhabditis elegans. Nat. Rev. Genet. 3:2002;356-369
48. Caenorhabditis elegans sequencing consortium. Genome sequence of the nematode C. elegans: a platform for investigating biology. Science. 282:1998;2012-2018
49. Fire A., et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 391:1998;806-811
50. Goutte C., et al. APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos. Proc. Natl. Acad. Sci. U. S. A. 99:2002;775-779
51. Francis R., et al. aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev. Cell. 3:2002;85-97
52. Ashrafi K., et al. Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature. 421:2003;268-272
53. Stark G.R., Gudkov A.V. Forward genetics in mammalian cells: functional approaches to gene discovery. Hum. Mol. Genet. 8:1999;1925-1938
54. Grimm S. The art and design of genetic screens: mammalian culture cells. Nat. Rev. Genet. 5:2004;179-189
55. Elbashir S.M., et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:2001;494-498
56. Yu J.Y., et al. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 99:2002;6047-6052
57. Lee N.S., et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 20:2002;500-505
58. Berns K., et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature. 428:2004;431-437
59. Zheng L., et al. An approach to genome-wide screens of expressed small interfering RNAs in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 101:2004;135-140
60. Aza-Blanc P., et al. Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening. Mol. Cell. 12:2003;627-637
61. Bridge A.J., et al. Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34:2003;263-264
62. Jackson A.L., Linsley P.S. Noise amidst the silence: off-target effects of siRNAs? Trends Genet. 20:2004;521-524
63. Guo G, et al. Mismatch repair genes identified using genetic screens in Blm-deficient embryonic stem cells. Nature. 429:2004;891-895
64. Yusa K, et al. Genome-wide phenotype analysis in ES cells by regulated disruption of Bloom's syndrome gene. Nature. 429:2004;896-899
65. Stockwell B.R. Chemical genetics: ligand-based discovery of gene function. Nat. Rev. Genet. 1:2000;116-125
66. Peterson R.T., et al. Small molecule developmental screens reveal the logic and timing of vertebrate development. Proc. Natl. Acad. Sci. U. S. A. 97:2000;12965-12969
67. Peterson R.T., et al. Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat. Biotechnol. 22:2004;595-599
68. Kwon H.J., et al. Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase. Proc. Natl. Acad. Sci. U. S. A. 95:1998;3356-3361
69. Stockwell B.R., et al. High-throughput screening of small molecules in miniaturized mammalian cell-based assays involving post-translational modifications. Chem. Biol. 6:1999;71-83
70. Huang J., et al. Finding new components of the target of rapamycin (TOR) signaling network through chemical genetics and proteome chips. Proc. Natl. Acad. Sci. U. S. A. 101:2004;16594-16599